Appendix 4C - Q4 FY21 Quarterly Cash Flow Report
Publication in Presents to MST Access Australian Micro & Small Caps Conference Cash balance at 30 June 2021 of A$28M MELBOURNE, Australia, July 30, 2021 /PRNewswire/ — Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, releases its Appendix 4C Quarterly Cash Flow Report and update on company activities for the quarter ending 30 June 2021 (Q4 FY21). The Company’s cash position at 30 June 2021 of $28M was bolstered by the receipt of $17M in net...